Company: LIDRW
Filing Date: 2025-02-24
Form Type: 10-K
Source: 0001437749-25-004906
Chunk: 173

Company: AEye, Inc.
Filing Date: 2025-02-24
Form: 10-K
Item: Item 1
Chunk 173
---
/2022, for which Mr. Dussan’s spouse is the beneficiary and Mr. Dussan is the trustee, and 12,402 shares of common stock held of record by the Luis Carlos Dussan Family Trust dated January 20, 2021, however, with respect to the shares held in this trust, Mr. Dussan disclaims beneficial ownership except to the extent of his pecuniary interest therein. 

      (4) 
      Consists of 238,520 shares held of record by Mr. Fisch. 

      (5) 
      Consists of 35,435 shares of common stock held of record by Prof. Dr. Gottschalk and options to purchase 2,480 shares of common stock. 

      (6) 
      Consists of 29,647 shares of common stock held of record by Mr. Husby. 

      (7) 
      Consists of 32,976 shares of common stock held of record by Ms. Zeifman. 

      (8) 
      Consists of 72,245 shares of common stock held of record by Mr. Hughes and 1,792 shares of common stock subject to equity awards held by Mr. Hughes that are expected to vest within 60 days of February 18, 2025. 

      (9) 
      Consists of 125,600 shares of common stock held of record by Mr. Tierney. 

      (10) 
      Consists of 909,986 shares of common stock held of record and 4,892 shares of common stock subject to equity awards that are expected to vest and/or be exercisable within 60 days of February 18, 2025. 

Equity Compensation Plan Information

The table below provides information relating to our equity compensation plans, including individual compensation arrangements, under which our common stock is authorized for issuance as of December 31, 2024, as adjusted for stock splits:

      Number of securities to be issued upon exercise of outstanding options, warrants and rights 

      Weighted average exercise price of outstanding options, warrants and rights 

      Number of securities remaining available for future issuance under equity compensation plans 

      Equity compensation plans approved by security holders: 

      2023 CEO Inducement Grant Plan 

     84,374

     $
     0

     0

      2021 Equity Incentive Plan 

     299,812
     (1)
      
     $